candesartan has been researched along with Asthma in 3 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
Asthma: A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Angiotensin II is a putative mediator in bronchial asthma." | 9.10 | Effect of candesartan, a type 1 angiotensin II receptor antagonist, on bronchial hyper-responsiveness to methacholine in patients with bronchial asthma. ( Fujimura, M; Hashimoto, T; Ishiura, Y; Kamio, Y; Kita, T; Myou, S; Nakao, S; Watanabe, K, 2002) |
| "Candesartan, an AT(1) receptor antagonist, has been reported to have no association with persistent cough in subjects with hypertension, but there has been no study on the safety of its administration to hypertensive patients with symptomatic asthma." | 9.09 | Effects of candesartan on cough and bronchial hyperresponsiveness in mildly to moderately hypertensive patients with symptomatic asthma. ( Abe, S; Hashimoto, M; Oashi, K; Saikai, T; Suzuki, K; Tanaka, H; Tanaka, S; Teramoto, S, 2001) |
| "The effects of candesartan and irbesartan, antagonists of the type I angiotensin II receptor, were investigated on allergic asthma." | 7.91 | Suppressive effects of type I angiotensin receptor antagonists, candesartan and irbesartan on allergic asthma. ( Im, DS; Kim, MJ, 2019) |
| "Angiotensin II is a putative mediator in bronchial asthma." | 5.10 | Effect of candesartan, a type 1 angiotensin II receptor antagonist, on bronchial hyper-responsiveness to methacholine in patients with bronchial asthma. ( Fujimura, M; Hashimoto, T; Ishiura, Y; Kamio, Y; Kita, T; Myou, S; Nakao, S; Watanabe, K, 2002) |
| "Candesartan, an AT(1) receptor antagonist, has been reported to have no association with persistent cough in subjects with hypertension, but there has been no study on the safety of its administration to hypertensive patients with symptomatic asthma." | 5.09 | Effects of candesartan on cough and bronchial hyperresponsiveness in mildly to moderately hypertensive patients with symptomatic asthma. ( Abe, S; Hashimoto, M; Oashi, K; Saikai, T; Suzuki, K; Tanaka, H; Tanaka, S; Teramoto, S, 2001) |
| "The effects of candesartan and irbesartan, antagonists of the type I angiotensin II receptor, were investigated on allergic asthma." | 3.91 | Suppressive effects of type I angiotensin receptor antagonists, candesartan and irbesartan on allergic asthma. ( Im, DS; Kim, MJ, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, MJ | 1 |
| Im, DS | 1 |
| Myou, S | 1 |
| Fujimura, M | 1 |
| Kamio, Y | 1 |
| Kita, T | 1 |
| Watanabe, K | 1 |
| Ishiura, Y | 1 |
| Hashimoto, T | 1 |
| Nakao, S | 1 |
| Tanaka, H | 1 |
| Teramoto, S | 1 |
| Oashi, K | 1 |
| Saikai, T | 1 |
| Tanaka, S | 1 |
| Suzuki, K | 1 |
| Hashimoto, M | 1 |
| Abe, S | 1 |
2 trials available for candesartan and Asthma
| Article | Year |
|---|---|
Effect of candesartan, a type 1 angiotensin II receptor antagonist, on bronchial hyper-responsiveness to methacholine in patients with bronchial asthma.
Topics: Administration, Inhalation; Adult; Aged; Angiotensin II; Angiotensin Receptor Antagonists; Asthma; B | 2002 |
Effects of candesartan on cough and bronchial hyperresponsiveness in mildly to moderately hypertensive patients with symptomatic asthma.
Topics: Adult; Aged; Antihypertensive Agents; Asthma; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Br | 2001 |
1 other study available for candesartan and Asthma
| Article | Year |
|---|---|
Suppressive effects of type I angiotensin receptor antagonists, candesartan and irbesartan on allergic asthma.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Allergic Agents; Asthma; Benzimidazoles; Biph | 2019 |